Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China flag China · Delayed Price · Currency is CNY
20.12
-0.14 (-0.69%)
Feb 13, 2026, 3:04 PM CST

SHE:300482 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
2,5693,0602,7605,6743,3542,805
Other Revenue
5.075.075.226.897.115.82
2,5743,0652,7655,6813,3612,811
Revenue Growth (YoY)
-12.52%10.85%-51.33%69.01%19.57%35.64%
Cost of Revenue
980.781,1071,0402,7471,396870.75
Gross Profit
1,5931,9571,7252,9331,9651,940
Selling, General & Admin
911.12905.85877.111,157910.24819.99
Research & Development
405.43411.52378418.84391.09279.43
Other Operating Expenses
37.6714.039.5115.959.049.63
Operating Expenses
1,3771,3671,2681,6091,3301,115
Operating Income
215.87590.27456.731,324634.64825.49
Interest Expense
-32.98-30.47-29.93-32.53-27.76-11.14
Interest & Investment Income
20.9120.5358.7164.9350.4840.51
Currency Exchange Gain (Loss)
11.4611.4610.9930.58-20.62-23.62
Other Non Operating Income (Expenses)
-2.19-4.16-0.59-6.59-5.67-3.96
EBT Excluding Unusual Items
213.08587.63495.911,381631.08827.28
Impairment of Goodwill
---3.95-38.56-5.87-71.74
Gain (Loss) on Sale of Investments
26.3825.7514.812.8110.550.24
Gain (Loss) on Sale of Assets
0.020.760.08-10.4-10.34-2.51
Asset Writedown
-13.8-5.96-10.77-29.96--44.37
Other Unusual Items
37.5621.2944.750.1155.0722.04
Pretax Income
263.25629.46540.761,365680.49730.93
Income Tax Expense
11.4164.2553.33174.4147.91114.13
Earnings From Continuing Operations
251.83565.22487.431,190632.58616.81
Minority Interest in Earnings
7.6-3.590.26.941.8517.36
Net Income
259.43561.63487.621,197634.43634.17
Net Income to Common
259.43561.63487.621,197634.43634.17
Net Income Growth
-50.47%15.18%-59.27%88.68%0.04%63.67%
Shares Outstanding (Basic)
475464443442444440
Shares Outstanding (Diluted)
475464443442444440
Shares Change (YoY)
2.81%4.71%0.36%-0.44%0.74%-0.33%
EPS (Basic)
0.551.211.102.711.431.44
EPS (Diluted)
0.551.211.102.711.431.44
EPS Growth
-51.82%10.00%-59.41%89.51%-0.69%64.22%
Free Cash Flow
9.3843.5-104.051,099208.44642.33
Free Cash Flow Per Share
0.020.09-0.232.490.471.46
Dividend Per Share
0.4000.4000.4000.5000.3000.385
Dividend Growth
---20.00%66.67%-22.00%100.00%
Gross Margin
61.89%63.87%62.37%51.64%58.46%69.02%
Operating Margin
8.39%19.26%16.52%23.31%18.88%29.37%
Profit Margin
10.08%18.32%17.64%21.07%18.88%22.56%
Free Cash Flow Margin
0.36%1.42%-3.76%19.35%6.20%22.85%
EBITDA
387.89796.73709.11,569817.3965.33
EBITDA Margin
15.07%26.00%25.65%27.62%24.32%34.34%
D&A For EBITDA
172.01206.45252.37244.63182.66139.85
EBIT
215.87590.27456.731,324634.64825.49
EBIT Margin
8.39%19.26%16.52%23.31%18.88%29.37%
Effective Tax Rate
4.33%10.21%9.86%12.78%7.04%15.61%
Revenue as Reported
2,5743,0652,7655,6813,3612,811
Advertising Expenses
-----221.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.